Day: April 12, 2024

NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) — Evome Medical Technologies Inc (the “Company” or “Evome”) highlighted the strengthening credit relationship with Pathward, N.A. (“Pathward”), the Company’s senior lender. As the Company works to sell non-core business units to reduce acquisition debt in an effort to improve operational profitability, Pathward provides working capital to fuel revenue growth of the Company’s new Biodex products. Pathward has featured the strong and growing relationship with Evome as an example of its willingness to fund growth companies: Evome Medical Technologies enjoys multi-year expansion with financing from Pathward Web link:https://www.pathward.com/news/evome-medical-technologies-enjoys-multi-year-expansion-with-fina/ This focus on revenue growth and market expansion has led the Company’s operating...

Jeremy Gowler appointed Interim CEO WALTHAM, Mass., April 12, 2024 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today announced that the company’s Board of Directors has appointed Jeremy Gowler as Interim Chief Executive Officer (CEO), effective immediately, while the Board institutes a search for a permanent CEO. Mr. Gowler succeeds Dave Hering. “The Invivyd Board of Directors is positioning the company for its next phase of growth,” said Marc Elia, Chairperson. “Invivyd is poised to lead a brand-new paradigm in delivering novel, impactful monoclonal antibody (mAb) therapies for the pre-exposure prophylaxis (PrEP) of COVID-19, and we wish to fully unlock this capability and associated value creation. In the interim, we...

CARLSBAD, Calif., April 12, 2024 (GLOBE NEWSWIRE) — AppTech Payments Corp. (“AppTech”) (NASDAQ: APCX), a pioneering Fintech company powering frictionless commerce, announced today it filed its proxy statement and will hold its Annual Shareholder Meeting on May 29, 2024, at 10:00 AM PST. To enable shareholders to attend regardless of their location, AppTech will hold the meeting virtually. Meeting details and instructions to access proxy materials have been disseminated to shareholders of record via direct mail in accordance with the notice and access model. Shareholders of record as of the April 5, 2024, record date are entitled to the notice of the Annual Meeting or any adjournment thereof. If you are a shareholder and have not received notice by May 1, 2024, please contact AppTech to obtain meeting details. About AppTech Payments...

Coop Pank invites shareholders, investors, analysts and other stakeholders to join its investor webinar, scheduled on 18 April 2024 at 9 am (EET). The webinar will be held in Estonian. The webinar will be hosted by the Chairman of the Board Margus Rink and the Chief Financial Officer Paavo Truu, who present the unaudited financial results of the First Quarter of 2024. During the webinar all attendees can ask questions. All questions will be answered after the presentation. To join the webinar, you need to register in advance via following link: https://bit.ly/CP-180424-registreerimine Registrants will be sent a link to the webinar and a reminder email one hour before the start of the webinar. The webinar will be recorded and published on the company’s website www.cooppank.ee and on our YouTube account. Coop Pank, based on Estonian...

April 12, 2024 SBM Offshore is pleased to announce that ExxonMobil Guyana Limited (“EMGL”) has confirmed the award of contracts for the Whiptail development project located in the Stabroek Block in Guyana. Under these contracts, SBM Offshore will construct and install FPSO Jaguar. Ownership will transfer to EMGL prior to the FPSO’s installation in Guyana, and SBM Offshore expects to operate the FPSO for 10 years under the Operations and Maintenance Enabling Agreement signed in 2023. The award follows completion of front-end engineering and design studies, receipt of requisite government approvals and the final investment decision on the project by ExxonMobil and block co-venturers. The Whiptail development is the sixth development within the Stabroek block, circa 200 kilometers offshore Guyana. EMGL is the operator and holds a 45 percent...

Recycling FPSO Petróleo Nautipa in compliance with Hong Kong Convention BW Offshore has signed an agreement to recycle FPSO Petróleo Nautipa in compliance with the Hong Kong International Convention at Baijnath Melaram ship recycling facility (the “Facility”) in India. The Facility is certified to ISO standards and has been issued with a Statement of Compliance by the ship classification society Class NK in accordance with IMO Resolution MEPC.210(63) and the Hong Kong International Convention for the safe and environmentally sound recycling of ships. BW Offshore intend to have BW Offshore personnel continuously at the site during the recycling period, supplemented by additional competent personnel from a third party, to ensure Health, Safety and Environmental regulations are followed. A Ship Recycling Plan will be prepared and provided...

The Board of Directors of Fluxys Belgium SA has the honour to invite the shareholders of the company to attend the ordinary general meeting to be held on Tuesday 14 May 2024 from 2.30 pm at the BNP Event Center, Rue Royale 20, 1040 Brussels. Download below the notice of meeting for the ordinary general meeting in Dutch or French. The other documents related to the ordinary general meeting as well as the integrated annual report 2023 are available on the Fluxys Belgium website.

BROOKFIELD, NEWS, April 12, 2024 (GLOBE NEWSWIRE) — Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) is set to publish its financial results for the first quarter 2024 on May 8, 2024, prior to 7:00 a.m. ET. These results will be made available on our website at www.bam.brookfield.com/news-events/press-releases. The Company will host an earnings conference call and webcast to review its results and operations beginning at 11:00 a.m. ET. Participants can join by conference call or webcast: Conference CallPlease pre-register by conference call: https://register.vevent.com/register/BIc6f8169c26b54bd08c368c2ce6fe8cf9 Upon registering, you will be emailed a dial-in number, and unique PIN. This process will bypass the operator and avoid the queue.WebcastPlease join and register by webcast: https://edge.media-server.com/mmc/p/7jzhjj76 Replay...

  PRESS RELEASE – PRIVILEGED INFORMATION Mont-Saint-Guibert, Belgium, 12 April 2024, 12:00 CET – BioSenic (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, as part of the global restructuring plan announced on 11 April 2024, provides information on (i) the Company’s current debt position and the potential impact of the plan on this position and (ii) links to the Company’s website to consult the conversion terms and conditions offered to holders of convertible bonds (excluding Global Tech Opportunities 15) as part of the plan. The impact that the global restructuring plan could have on BioSenic’s debt position is as follows:    Due Paid within 5 years 31/12/2030 + 24 monthsExtraordinary lease  €               61 211,77  €                              ...